Bruce Power

About Bruce Power

Bruce Power operates in the Other / Uncategorized space and is among the firms Bracken expects to track at SNMMI 2026.

Longer summary placeholder. Replace once Bracken finalizes the exhibitor profile copy.

What we're seeing

• Nuclear Medicine Today · 2026-07-06
  Bruce Power files IND for next-generation PSMA-targeted agent
  Details remain limited but analysts read the move as a positioning play ahead of pivotal data.
• PR Newswire · 2026-08-01
  Bruce Power partners with academic center on Actinium-225 program
  The work builds on more than a decade of radiochemistry collaboration.
• Imaging Wire · 2026-09-04
  Bruce Power closes Series C round to scale radiopharma manufacturing
  Details remain limited but analysts read the move as a positioning play ahead of pivotal data.
• STAT News · 2026-02-11
  Bruce Power publishes dosimetry data at SNMMI 2026
  The announcement comes amid tightening Mo-99 and Lu-177 supply.
• FierceBiotech · 2026-03-06
  Bruce Power appoints new Chief Medical Officer ahead of pivotal trial
  Coverage notes the company's growing footprint in the radioligand therapy space.

Mocked while we wire the Exa integration. Headlines are illustrative.

What we expect to see at the booth

Booth talking points, demos, and announcements to watch for. Bracken analyst note coming.